✦ LIBER ✦

Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer

✍ Scribed by Shannon R. Payne; Beth Newman; Mary-Claire King

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 154 KB
Volume: 29
Category: Article
ISSN: 1045-2257
DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1008>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical management of BRCA1- and BRCA2-

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

Frequency of BRCA1 and BRCA2 germline mu

Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

✍ Noriko Ikeda; Yasuo Miyoshi; Kohri Yoneda; Eiichi Shiba; Yoshizo Sekihara; Morit 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 2 views

German family study on hereditary breast

German family study on hereditary breast and/or ovarian cancer: Germline mutation analysis of the BRCA1 gene

✍ Ute Hamann; Hiltrud Brauch; Alex M. Garvin; Gunther Bastert; Rodney J. Scott 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Women harboring BRCA1 germline mutations carry an 85% lifetime risk of developing breast cancer and a 63% risk of ovarian cancer. In this first systematic study of familial breast and/or ovarian cancer in Germany we investigated 29 families for germline mutations in the BRCA1 gene. We identified mut

Founder BRCA1 mutations and two novel ge

Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland

✍ Marco van der Looij; Barbara Wysocka; Izabela Brozek; Jacek Jassem; Janusz Limon 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes account for the majority of high-risk breast/ovarian cancer families, depending on the population studied. Previously, BRCA1 mutations were described in women from Western Poland. To further characterize the spectrum of BRCA1 mutations and the impact o

Low incidence of BRCA1 mutations among I

Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer

✍ Manuela Santarosa; Alessandra Viel; Riccardo Dolcetti; Diana Crivellari; Maria D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 2 views

Most familial breast or ovarian cancers are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2. The cloning of these genes has opened a new era for the genetic counseling of women with a family history of breast or ovarian cancer. To estimate the incidence of d

Mutational analysis of BRCA1 and BRCA2 g

Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations

✍ Ui-Soon Khoo; Hextan Y.S. Ngan; Annie N.Y. Cheung; Kelvin Y.K. Chan; Jing Lu; Vi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views